JEWISH TIME PODCAST JEWISH TIME PODCAST SUBSCRIBE TODAY SUBSCRIBE TODAY
search
Pfzifer
This October 2021 photo provided by Pfizer shows kid-size doses of its COVID-19 vaccine in Puurs, Belgium. The vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday, Oct. 22, as the U.S. considers opening vaccinations to that age group. (Pfizer via AP)
October 26, 2021, 10:47 am
FDA Expected to Authorize Pfizer COVID Vaccine for Kids 5-11
Israel planning to follow suit after its own approval process, as soon as mid-November.
By AFP and TOI STAFF
Load More